Pericardial effusion (PE) is occasionally reported in children with Down's syndrome (DS) either in isolation 1 (isolated PE) or as part of hydrops.
of inspired oxygen) 0.3, pallor (Hb 83 g/L), normal cardiovascular examination with normal noninvasive blood pressure (60/ 32, mean: 45), massive hepatomegaly (6 cm below costal margin) in the background of phenotypic DS. There was no hydrops, ascites or splenomegaly. He was stabilized with mechanical ventilation and packed cell transfusion (10 mL/kg twice). His liver function and coagulation profile were deranged: alanine transaminase (ALT) 318 IU/L, aspartate transaminase (AST) 1,147 IU/L; total bilirubin 41 micromol/L, direct bilirubin 6 micromol/L; alkaline phosphatase 163 IU/L; gamma glutamyl transferase (GGT) 389 IU/L; prothrombin time 46 second; activated partial thromboplastin time (APTT) 128 second international normalized ratio (INR) 5.2; fibrinogen 1.2 g/L; ammonia 69 micromol/L. There was no spontaneous bleeding. He received fresh frozen plasma (10 mL/kg). Echocardiography showed normal structure apart from a generous interatrial communication with predominant left to right shunt. There was a global pericardial effusion measuring 5 mm in four chamber view in diastole, with a larger pocket located anteromedially (►Fig. 1). There was a good biventricular function and no evidence of tamponade.
Over the next 6 hours, he developed progressively worsening hypotension (lowest invasive BP [blood pressure] of 31/18, mean: 23) refractory to volume boluses and multiple inotropes (Dopamine 20 microgram/kg/min; Dobutamine 20 microgram/kg/min; adrenaline 0.5 microgram/kg/min) in escalating doses. Blood pressure started to improve after commencing hydrocortisone (2 mg/kg/loading dose, once followed by 1 mg/ kg/dose 6 hourly). Cortisol level was not obtained prior to commencing. In view of multitude of problems he was transferred to the Children's Hospital for further management.
Echocardiography on admission to the Children's Hospital confirmed the same findings.
Inotropes were weaned slowly and stopped after 48 hours. He was extubated to continuous positive airway pressure (CPAP) on day 3 and hydrocortisone was stopped the next day. He remained normotensive without hydrocortisone until day 19. Pericardial effusion was also completely resolved over next 2 weeks. Haematological findings were investigated. Kleihauer's test result indicated 37 mL fetal blood loss that accounted for the initial anemia (Hb 83 g/L). However, white cell count was elevated (30.1 Â 10 9 /L) and blood film showed blast cells (2.1 Â 10 9 /L). Although the initial platelet count was normal (190 Â 10 9 /L) there was a subsequent drop in the count over next few days (lowest 26 Â 10 9 /L). This prompted a bone marrow examination that showed 15% blast cells confirming the diagnosis of TMD. The thyroid function test revealed a raised TSH (thyroid stimulating hormone; 28.05 mU/L) and low normal T4 (14.6 pmol/L) confirming subclinical hypothyroidism. He was commenced on L-thyroxine treatment that normalized thyroid function.
On day 19, he developed an acute deterioration with severe hypotension (lowest BP 39/12 with the mean of 21 mm Hg), was mechanically ventilated and commenced on volume bolus followed by inotropes (Adrenaline 0.2 microgram/kg/min and Dobutamine 10 microgram/kg/min) to which he did not respond. He was then restarted on hydrocortisone at 1 mg/ kg/dose 6 hourly with good response. Unfortunately, no cortisol level was obtained prior to commencing on hydrocortisone. He was continued on maintenance dose of hydrocortisone with a view to wean it at a later stage and perform an ACTH (adrenocorticotropic hormone) stimulation test (synacthen test); however, this was not achieved prior to his death.
He developed progressive liver failure, splenomegaly with ascites. Investigations showed elevated transaminases and deranged coagulation profile. TORCH screening (Toxoplasma, Others, Rubella Cytomegalovirus, Herpes Simplex Virus), metabolic work-up including α1 antitrypsin, urine metabolic screen, and transferrin isoform were negative. Tense ascites needed peritoneal drainage of large amount of transudate. Ultrasound showed coarse echogenicity consistent with liver fibrosis/ cirrhosis and collaterals suggestive of portal hypertension. Multidisciplinary team opined that in view of continued deterioration despite maximal supportive therapy in the background of multiple issues, redirection of care was thought to be in his best interest. The family accepted the offer of palliative care course. He died on day 39, soon after extubation in the presence of his family. The post mortem autopsy was not performed as per the parental request.
Discussion
Our case with DS exhibited isolated PE without hydrops, TMD, hypothyroidism, liver failure with portal hypertension and possible adrenal insufficiency. The literature review (summarized in ►Table 1) was undertaken to establish the etiopathogenesis, presentation, associated findings, natural course, and management of fetal and neonatal pericardial effusion. 
Pathogenesis of PE in DS

Age of Onset
Most of the reported cases have been diagnosed either in the second or third trimester as PE is easily detected with ultrasound. PE has been diagnosed as early as (11 6 
Cardiac Manifestation
In most reported cases the heart was structurally normal but some have reported associated ASD (atrial septal defect), Occasionally, PE can be associated with acute myeloid leukemia 9 and congenital hypothyroidism. 1 Our patient had TMD and
hypothyroidism. An interesting finding in our case was the temporal association between the administration of hydrocortisone and resolution of circulatory collapse on more than one occasion creating a convincing argument for possible adrenal insufficiency . Such an association has not been previously reported to the best of our knowledge.
Treatment
In utero been used to facilitate resolution of PE. Occasionally a prolonged course of steroid over 6 6 to 12 weeks 13 was required to achieve resolution of PE. Most of the cases of PE are associated with TMD. TMD has favorable outcome with complete remission within the first 3 months in most cases; however, in infants with severe and life-threatening symptoms (high white cell count, bleeding diatheses, liver fibrosis, and effusion) treatment with low dose cytarabine (1 mg/kg/day Â 7days) has a beneficial effect. 18 In two term neonates with haemodynamically significant PE associated with TMD, a short course of cytarabine resulted in remarkable improvement and resolution of PE. 11 Oh et al 12 have used low-dose cytarabine in their patient with a large PE associated with TMD to prevent the development of hepatic fibrosis and achieved complete resolution of PE and TMD. In one of the case reports 1 thyroxine was used for hypothyroidism but it was started when PE had already resolved with steroid therapy. In our case, the short course of hydrocortisone for first 3 days given for the management of hypotension may have expedited resolution of PE. It had already resolved by the time thyroxine was commenced, thereby negating its role in facilitating PE resolution in our case.
Outcome
The outcome of neonates with PE in DS is difficult to ascertain as sometimes the parents opt for termination of pregnancy.
10,17
The prognosis is worse if PE is associated 
Conclusion
Our case report along with a comprehensive review of other case reports of perinatal onset of PE in DS indicate that PE can be isolated or part of hydrops, asymptomatic or present with tamponade, can have associated cardiac and noncardiac anomalies, the most common being TMD. PE in association with TMD and liver failure has been reported to have a poor prognosis as in our case. PE usually resolves spontaneously but sometimes need medications (prednisolone/cytarabine). PE associated with adrenal insufficiency in DS has not been previously described. While not proven, we assume this baby had adrenal insufficiency based on the temporal association between resolution of hypotension and commencement of hydrocortisone at two different time points during the course.
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